Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pharmacogenomic biomarkers for personalized cancer treatment.

Journal of internal medicine - 1 Feb 2015

Rodríguez-Antona C, Taron M

Abstract excerpt

Personalized medicine involves the selection of the safest and most effective pharmacological treatment based on the molecular characteristics of the patient. In the case of anticancer drugs, tumour cell alterations can have a great impact on drug activity and, in fact, most biomarkers predicting response originate from these cells. On the other hand, the risk of developing severe toxicity may be related to the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Clinical Trials as Topic
Share to Angiogenesis Inhibitors
Share to Evidence-Based Medicine

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Kidney Neoplasms

Share to Medical Oncology

Share to Pharmacogenetics

Share to Precision Medicine

Share to Predictive Value of Tests

Source

Identifiers

PMID: 25338550
DOI: 10.1111/joim.12321

Genes

EGFR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pharmacogenomic biomarkers for personalized cancer treatment.PMID 25338550Read ↗

Exploitation of Gene Expression and Cancer Biomarkers in Paving the Path to Era of Personalized MedicineSemantic proximity Read ↗

Molecular diagnostics and personalized medicine in oncology: challenges and opportunities.Semantic proximity Read ↗

Clinically relevant cancer biomarkers and pharmacogenetic assays.Semantic proximity Read ↗

Personalized Cancer Medicine: Molecular Diagnostics, Predictive biomarkers, and Drug ResistanceSemantic proximity Read ↗

Pharmacogenetics and pharmacogenomics of anticancer agents.Semantic proximity Read ↗

Role of genomics in identifying new targets for cancer therapy.Semantic proximity Read ↗

Approaches to the discovery of pharmacogenomic markers in oncology: 2000-2010-2020.Semantic proximity Read ↗

Cancer pharmacogenomics, challenges in implementation, and patient-focused perspectivesSemantic proximity Read ↗

Novel genetic and epigenetic factors of importance for inter-individual differences in drug disposition, response and toxicitySemantic proximity Read ↗

Cancer pharmacogenomics: DNA genotyping and gene expression profiling to identify molecular determinants of chemosensitivity.Semantic proximity Read ↗

Pharmacogenetics of conventional chemotherapy in non-small-cell lung cancer: a changing landscape?Semantic proximity Read ↗

Pharmacogenomics.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.